CARRERA CARRERA, Francesc,PEREZ GARCIA, Juan Bautista,VIDAL JUAN, Bernat,SANCHEZ IZQUIERDO, Francisco,SERRA COMA, Maria Carme
申请号：
PH12016502252
公开号：
PH12016502252A1
申请日:
2016.11.11
申请国别(地区):
PH
年份:
2017
代理人:
摘要：
The present invention is directed to novel pharmaceutically acceptable, addition salts of (S)-2-(1-(6-amino-5-cyanopyrimidin-4-ylamino)ethyl)-4-oxo-3-phenyl-3,4- dihydropyrrolo[1,2-f][1,2,4]triazine-5-carbonitrile with sulfonic acid derivatives, in particular with methanesulfonic acid, naphthalene-2-sulfonic acid and para-toluenesulfonic acid, and pharmaceutically acceptable solvates thereof, and their use as Phosphoinositide 3-Kinase (PI3K) inhibitors.
